GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes.
BACKGROUND
Advances in generating genome-wide gene expression data have accelerated the development of molecular-based tumor classification systems. Tools that allow the translation of such molecular classification schemas from research into clinical applications are still missing in the emerging era of personalized medicine.


RESULTS
We developed GliomaPredict as a computational tool that allows the fast and reliable classification of glioma patients into one of six previously published stratified subtypes based on sets of extensively validated classifiers derived from hundreds of glioma transcriptomic profiles. Our tool utilizes a principle component analysis (PCA)-based approach to generate a visual representation of the analyses, quantifies the confidence of the underlying subtype assessment and presents results as a printable PDF file. GliomaPredict tool is implemented as a plugin application for the widely-used GenePattern framework.


CONCLUSIONS
GliomaPredict provides a user-friendly, clinically applicable novel platform for instantly assigning gene expression-based subtype in patients with gliomas thereby aiding in clinical trial design and therapeutic decision-making. Implemented as a user-friendly diagnostic tool, we expect that in time GliomaPredict, and tools like it, will become routinely used in translational/clinical research and in the clinical care of patients with gliomas.
Li
Aiguo
A
Neuro-Oncology Branch, National Cancer Institute, National Institutes of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Bozdag
Serdar
S
Kotliarov
Yuri
Y
Fine
Howard A
HA
D000465:Algorithms; D015870:Gene Expression; D020869:Gene Expression Profiling / Q000379:methods*; D005910:Glioma / Q000145:classification / Q000235:genetics*; D006801:Humans; D025341:Principal Component Analysis; D012984:Software; D057170:Translational Research, Biomedical